| Title: | Development and validation of a blood biomarker score for predicting mortality risk in the general population |
| Journal: | Journal of Translational Medicine |
| Published: | 15 Jul 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/37454089/ |
| DOI: | https://doi.org/10.1186/s12967-023-04334-w |
| URL: | https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-023-04334-w |
| Citations: | 1 (1 in last 2 years) as of 8 Aug 2024 |
Publication 11631
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundBlood biomarkers for multiple pathways, such as inflammatory response, lipid metabolism, and hormonal regulation, have been suggested to influence the risk of mortality. However, few studies have systematically evaluated the combined predictive ability of blood biomarkers for mortality risk.MethodsWe included 267,239 participants from the UK Biobank who had measurements of 28 blood biomarkers and were free of cardiovascular disease (CVD) and cancer at baseline (2006-2010). We developed sex-specific blood biomarker scores for predicting all-cause mortality risk in a training set of 247,503 participants from England and Wales, and validated the results in 19,736 participants from Scotland. Cox and LASSO regression analyses were performed to identify independent predictors for men and women separately. Discrimination and calibration were evaluated by C-index and calibration plots, respectively. We also assessed mediating effects of the biomarkers on the association between traditional risk factors (current smoking, obesity, physical inactivity, hypertension, diabetes) and mortality.ResultsA total of 13 independent predictive biomarkers for men and 17 for women were identified and included in the score development. Compared to the lowest tertile of the score, the highest tertile showed a hazard ratio of 5.36 (95% confidence interval [CI] 5.04-5.71) in men and 4.23 (95% CI 3.87-4.62) in women for all-cause mortality. In the validation set, the score yielded a C-index of 0.73 (95% CI 0.72-0.75) in men and 0.70 (95% CI 0.68-0.73) in women for all-cause mortality; it was also predictive of CVD (C-index of 0.76 in men and 0.79 in women) and cancer (C-index of 0.70 in men and 0.67 in women) mortality. Moreover, the association between traditional risk factors and all-cause mortality was largely mediated by cystatin C, C-reactive protein, 25-hydroxyvitamin D, and hemoglobin A1c.ConclusionsWe established sex-specific blood biomarker scores for predicting all-cause and cause-specific mortality in the general population, which hold the potential to identify high-risk individuals and improve targeted prevention of premature death.</p>
9 Authors
- Jing Yang
- Jiayi Lu
- Junyan Miao
- Jiacong Li
- Meng Zhu
- Juncheng Dai
- Hongxia Ma
- Guangfu Jin
- Dong Hang
1 Application
| Application ID | Title |
|---|---|
| 52217 | Serum cardiometabolic biomarkers in relation to all-cause and cause-specific mortality |
Enabling scientific discoveries that improve human health